These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 4199134

  • 1. Human leukocyte migration inhibition as an indicator of cellular hypersensitivity to soluble antigens.
    Rauch HC, King K.
    Int Arch Allergy Appl Immunol; 1973; 44(6):862-74. PubMed ID: 4199134
    [No Abstract] [Full Text] [Related]

  • 2. Leukocyte migration inhibition by dental plaque antigens as indicated by the capillary tube and the agarose plate technique.
    Budtz-Jörgensen E, Kelstrup J, Budtz-Jörgensen A.
    J Periodontal Res; 1976 Apr; 11(2):86-95. PubMed ID: 132521
    [No Abstract] [Full Text] [Related]

  • 3. Murine spleen leukocytes as an inhibitable target cell system for human MIF.
    Górski AJ.
    Cell Immunol; 1974 May; 12(2):315-22. PubMed ID: 4617631
    [No Abstract] [Full Text] [Related]

  • 4. [Inhibition of leukocyte migration in tuberculosis and diseases with cutaneous energy].
    Lenzini L, Rottoli L, Rottoli P.
    Ann Sclavo; 1974 May; 16(1):29-56. PubMed ID: 4529204
    [No Abstract] [Full Text] [Related]

  • 5. Correlation of PPD and BCG-induced leukocyte migration inhibition, delayed cutaneous hypersensitivity, lymphocyte transformation in vitro and humoral antibodies to PPD in man.
    Fleer A, van der Hart M, Blok-Schut BJ, Schellekens PT.
    Eur J Immunol; 1976 Mar; 6(3):163-7. PubMed ID: 791653
    [Abstract] [Full Text] [Related]

  • 6. [Significance of the leukocyte migration inhibition test (MIT) in the study of cellular immunity].
    Steruská M, Chabronová J, Cupaníková D, Seichertová E.
    Vnitr Lek; 1977 Sep; 23(9):911-6. PubMed ID: 335648
    [No Abstract] [Full Text] [Related]

  • 7. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
    Knopf B, Wätzig V, Knöll B.
    Arch Geschwulstforsch; 1978 Sep; 48(8):722-8. PubMed ID: 753194
    [Abstract] [Full Text] [Related]

  • 8. [Streptococcal allergy. Correlation between clinical allergologic exploration and the leukocyte migration inhibition test (L.M.T.). Apropos of 68 cases].
    Saurat JH, Husson JM, Paupe J.
    Nouv Presse Med; 1972 May 20; 1(21):1409-13. PubMed ID: 5036696
    [No Abstract] [Full Text] [Related]

  • 9. Degrees of impairment of cell-mediated immune reactivity in Hodgkin's disease.
    Petrov M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976 May 20; 103(2):201-10. PubMed ID: 61913
    [No Abstract] [Full Text] [Related]

  • 10. Cellular immunity in man assessed by indirect migration inhibition test using murine spleen leukocytes.
    Górski A, Madalińska M, Droszcz W.
    Biomedicine; 1973 Jan 20; 19(1):19-21. PubMed ID: 4575691
    [No Abstract] [Full Text] [Related]

  • 11. Cellular immunity in man assessed by indirect migration inhibition test using murine spleen leukocytes.
    Górski A, Madalinska M, Droszcz W.
    Biomedicine; 1973 Jan 20; 19(1):19-21. PubMed ID: 4593322
    [No Abstract] [Full Text] [Related]

  • 12. [Studies of cellular sensitization to BCG and PPD using leukocyte cell migration inhibition].
    Lenzini L, Rottoli L, Rottoli P.
    Ann Sclavo; 1973 Jan 20; 17(5):660-7. PubMed ID: 782381
    [Abstract] [Full Text] [Related]

  • 13. [Hodgkin's disease: study of delayed hypersensitivity of 64 non treated patients. Value of epicutaneous test using croton oil].
    Goasguen J, Leblay R, Guerin D, Le Prise PY, Richier JL.
    Sem Hop; 1977 Jan 23; 53(4):219-25. PubMed ID: 189435
    [Abstract] [Full Text] [Related]

  • 14. Decreased correlation between the agarose leukocyte migration inhibition assay and delayed cutaneous hypersensitivity response to purified protein derivative in cancer patients.
    Chee DO, Holmes EC, Morton DL.
    J Natl Cancer Inst; 1978 Apr 23; 60(4):769-72. PubMed ID: 633387
    [No Abstract] [Full Text] [Related]

  • 15. Specific plasma factors blocking human maternal cell-mediated immune reaction to placental antigens.
    Youtananukorn V, Mantangkasombut P.
    Nat New Biol; 1973 Mar 28; 242(117):110-1. PubMed ID: 4513409
    [No Abstract] [Full Text] [Related]

  • 16. [Comparison between results of leukocyte migration inhibition test and skin hypersensitivity of tuberculin in man].
    Claudy A, Thivolet J, Valancogne A, Schmitt D.
    Rev Eur Etud Clin Biol; 1971 Oct 28; 16(8):826-30. PubMed ID: 5128513
    [No Abstract] [Full Text] [Related]

  • 17. Failure to demonstrate tumour-specific leucocyte migration inhibition in vitro by cryostat sections of breast cancer tissue.
    Petrini B, Bergstrand A, Wasserman J, Blomstedt B, Blomgren H, Baral E.
    Clin Oncol; 1977 Sep 28; 3(3):259-66. PubMed ID: 912961
    [No Abstract] [Full Text] [Related]

  • 18. Cellular hypersensitivity to tuberculin in BCG-revaccinated persons studied by skin reactivity, leucocyte migration inhibition and lymphocyte proliferation.
    Repo H, Kostiala AA, Kosunen TU.
    Clin Exp Immunol; 1980 Feb 28; 39(2):442-8. PubMed ID: 6993072
    [Abstract] [Full Text] [Related]

  • 19. Dissociation of correlates of cellular immunity in man: functional heterogeneity within the antigen-reactive cell population?
    Holt PG, Fimmel PJ, Bartholomaeus WN, Roberts LM, Tandon MK, Keast D.
    Int Arch Allergy Appl Immunol; 1976 Feb 28; 51(5):560-73. PubMed ID: 786903
    [Abstract] [Full Text] [Related]

  • 20. Ageing, immune response, and mortality.
    Roberts-Thomson IC, Whittingham S, Youngchaiyud U, Mackay IR.
    Lancet; 1974 Aug 17; 2(7877):368-70. PubMed ID: 4136513
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.